1367870-32-3

Basic information

• Product Name: 5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid
• Synonyms: 5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid
• CAS NO: 1367870-32-3
• Molecular Weight: 217.227
• Mol File: 1367870-32-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid(1367870-32-3)
• EPA Substance Registry System: 5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid(1367870-32-3)

Safety Data

• Hazardous Substances Data: 1367870-32-3(Hazardous Substances Data)

Upstream product

• 1015765-43-1 ethyl 5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carboxylate 
• 524729-53-1 ethyl 3-cyano-2-oxobutanoate 

Downstream Products

• 1610591-16-6 5-(3-(4-chloronaphthalen-1-yl)ureido)-N,4-dimethyl-1-phenyl-1H-pyrazole-3-carboxamide 
• 1414570-72-1 N'-acetyl-5-amino-4-methyl-1-phenyl-1H-pyrazole-3-carbohydrazide 
• 1610454-62-0 5-(3-(4,5-dichloro-2-(3-methoxypropyl)phenyl)ureido)-N,4-dimethyl-1-phenyl-1H-pyrazole-3-carboxamide 
• 1610455-26-9 5-amino-4-methyl-1-phenyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazole-3-carboxamide 
• 1610455-25-8 5-amino-4-methyl-N-(1-methylpiperidin-4-yl)-1-phenyl-1H-pyrazole-3-carboxamide 
• 1414570-60-7 5-amino-N,4-dimethyl-1-phenyl-1H-pyrazole-3-carboxamide 
• 1414570-70-9 4-methyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1-phenyl-1H-pyrazol-5-amine 
• 1610374-15-6 5-amino-N-methoxy-N,4-dimethyl-1-phenyl-1H-pyrazole-3-carboxamide 
• 1610373-94-8 1-(3-acetyl-4-methyl-1-phenyl-1H-pyrazol-5-yl)-3-((3S,4R)-4-(3,4-difluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)urea 
• 1610374-17-8 phenyl (3-acetyl-4-methyl-1-phenyl-1H-pyrazol-5-yl)carbamate 
• 1610374-16-7 1-(5-amino-4-methyl-1-phenyl-1H-pyrazol-3-yl)ethanone 

Relevant articles and documents

PYRAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula I: or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which ca

N-(MONOCYCLIC ARYL),N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.

N-BICYCLIC ARYL,N'-PYRAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.